These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6499181)

  • 1. Molecular characterization of an abnormal fibrinogen by two-dimensional electrophoresis.
    Polack B; Valiron O; Concord E; Freyssinet JM; Hudry-Clergeon G
    Clin Chem; 1984 Dec; 30(12 Pt 1):2093-7. PubMed ID: 6499181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A lower molecular weight gamma-chain variant in a congenital abnormal fibrinogen (Kyoto).
    Yoshida N; Okuma M; Moroi M; Matsuda M
    Blood; 1986 Sep; 68(3):703-7. PubMed ID: 3742050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinogen Adelaide: a familial hypodysfibrinogenaemia associated with abnormal alpha chains.
    Exner T; Barber S; Sage RE; Kronenberg H
    Br J Haematol; 1984 Jan; 56(1):95-106. PubMed ID: 6704329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substitution of gamma Arg-275 by Cys in an abnormal fibrinogen, "fibrinogen Osaka II". Evidence for a unique solitary cystine structure at the mutation site.
    Terukina S; Matsuda M; Hirata H; Takeda Y; Miyata T; Takao T; Shimonishi Y
    J Biol Chem; 1988 Sep; 263(27):13579-87. PubMed ID: 2971042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen Milano. VI: A heterozygous dysfibrinogenemia (A alpha 16 Arg----His) with bleeding tendency.
    Bögli C; Cofrancesco E; Cortellaro M; Della Volpe A; Hofer A; Furlan M; Zanussi C
    Eur J Haematol; 1990 Jul; 45(1):26-30. PubMed ID: 2379562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary dysfibrinogenaemia: structural and functional studies on three fibrinogen variants.
    Meyer M; Vogel G; Gromnica-Ihle E; Schellenberg I; Ostermann G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):499-502. PubMed ID: 2465961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective alpha-polymerization in the conversion of fibrinogen Baltimore to fibrin.
    Brown CH; Crowe MF
    J Clin Invest; 1975 Jun; 55(6):1190-4. PubMed ID: 1133167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of fibrinogen Milano I: amino acid exchange gamma 330 Asp----Val impairs fibrin polymerization.
    Reber P; Furlan M; Rupp C; Kehl M; Henschen A; Mannucci PM; Beck EA
    Blood; 1986 Jun; 67(6):1751-6. PubMed ID: 3708159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinogen Seattle releases half the normal amount of fibrinopeptide B.
    Branson HE; Schmer G; Theodor I; Pirkle H
    Acta Haematol; 1983; 70(4):257-63. PubMed ID: 6414212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen Sevilla, a congenital dysfibrinogenemia characterized by an abnormal monomer aggregation and a defective plasmin lysis.
    Fernández FJ; Noguerol P; Sosa R; Cuesta B; Páramo JA; Rocha E
    Clin Chim Acta; 1989 Feb; 179(3):239-50. PubMed ID: 2713997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysfibrinogenaemia characterized by abnormal fibrin monomer polymerization and normal fibrinopeptide A release.
    Lane DA; Cuddigan B; VanRoss M; Kakkar VV
    Br J Haematol; 1980 Mar; 44(3):483-94. PubMed ID: 6769460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An abnormal inherited fibrinogen (fibrinogen Genova) with delayed fibrin aggregation.
    Hassan HJ; Orlando M; Tonini GP; Casalbore P; Sarti A; Boeri E; Giacchino R; Tentori L; Mori PG
    Scand J Haematol; 1982 Oct; 29(4):287-94. PubMed ID: 7178834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative abnormality of an Aalpha chain molecular weight form in the fibrinogen of cirrhotic patients.
    Weinstein MJ; Deykin D
    Br J Haematol; 1978 Dec; 40(4):617-30. PubMed ID: 728374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma and platelet fibrinogen differ in gamma chain content.
    Francis CW; Nachman RL; Marder VJ
    Thromb Haemost; 1984 Feb; 51(1):84-8. PubMed ID: 6719392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Electrofocusing of abnormal fibrinogens in polyacrylamide gel].
    Soria J; Soria C; Durand G; Feger J
    Ann Biol Clin (Paris); 1972; 30(2):161-5. PubMed ID: 5040625
    [No Abstract]   [Full Text] [Related]  

  • 16. Abnormal fibrinogens with two structural defects.
    Matsuda M; Terukina S; Yoshida N; Yamazumi K; Maekawa H
    Adv Exp Med Biol; 1990; 281():63-72. PubMed ID: 2102626
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasmic degradation of fibrinogen Paris I.
    Budzynski AZ; Marder VJ
    J Lab Clin Med; 1976 Nov; 88(5):817-25. PubMed ID: 978044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Fibrinogen Tokyo II". An abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin molecules.
    Matsuda M; Baba M; Morimoto K; Nakamikawa C
    J Clin Invest; 1983 Sep; 72(3):1034-41. PubMed ID: 6886002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defect in the gamma polypeptide chain of a congenital abnormal fibrinogen (Paris I).
    Budzynski AZ; Marder VJ; Ménaché D; Guillin MC
    Nature; 1974 Nov; 252(5478):66-8. PubMed ID: 4427684
    [No Abstract]   [Full Text] [Related]  

  • 20. Dysfibrinogenaemia associated with a defect in the aggregation of the fibrin monomers (Almeria I fibrinogen). A preliminary study.
    Vila V; Regañon E; Fernandez-Pavon A; Aznar J
    Scand J Haematol; 1984 Nov; 33(5):460-5. PubMed ID: 6515329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.